KIDS OrthoPediatrics Corp

OrthoPediatrics Corp. Announces Distribution Agreement with Thrive Orthopedics LLC

OrthoPediatrics Corp. Announces Distribution Agreement with Thrive Orthopedics LLC

WARSAW, Ind., Jan. 22, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today that the Company gained distribution rights to bring additional bracing solutions to the US market through its OrthoPediatrics Specialty Bracing (OPSB) division.

OrthoPediatrics’ OPSB division has established a distribution agreement with Thrive Orthopedics LLC focused on three unique pediatric orthotic solutions. The Thrive Orthopedics F3 Hero Pediatric AFO is a lightweight carbon fiber ankle foot orthosis that provides the stability needed to improve walking while allowing flexibility and energy return at the correct moments to produce a more normalized, smooth, and dynamic walking pattern. This type of AFO is indicated for children who have challenges walking due to cerebral palsy, spina bifida, foot drop due to chemotherapy, or many other diagnoses. The TruStretch Pediatric Equinus Brace® is an innovative “above the knee” bracing solution that provides optimal stretching of the gastroc-soleus muscles for children with equinus deformity. The Thrive® Pediatric X-Glide Carbon Fiber Insoles come in both rigid and flexible foot plate styles and offer low profile and lightweight gait training tools.

Joe Hauser, OrthoPediatrics Specialty Bracing division President, commented, “The OPSB team is starting the new year off with exciting news. I am so proud of everything we are advancing to help more KIDS with non-operative care. The distribution agreement with Thrive Orthopedics represents the next phase of our planned growth, bringing more innovative solutions to children around the world.”

About OrthoPediatrics Corp.

Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets over 70 products that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and over 70 countries outside the United States. For more information, please visit For more information about the OrthoPediatrics Specialty Bracing portfolio, please visit .

About Thrive Orthopedics

Thrive Orthopedics was founded on one simple premise; to help practitioners and patients by designing and delivering the best carbon fiber AFOs in the world. We believe our products have the best function, craftsmanship, value, and warranty in the entire industry. We are delivering health with compassion and care.

Investor Contact

Philip Trip Taylor

Gilmartin Group



415-937-5406



EN
22/01/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on OrthoPediatrics Corp

 PRESS RELEASE

Global POISE Study Reaches Milestone of 600 Orthopedic Implants in Ped...

Global POISE Study Reaches Milestone of 600 Orthopedic Implants in Pediatric Patients, Advancing Research on the Safety and Efficacy of OrthoPediatrics® Products WARSAW, Ind., July 16, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced a significant milestone in the ongoing Global POISE (Pediatric Orthopedic Implant Safety and Efficacy) Study: more than 600 implants are now being observed across 300+ pediatric patients as part of this study. ...

 PRESS RELEASE

OrthoPediatrics Corp. Continued Leading Sponsorship at 2025 POSNA Annu...

OrthoPediatrics Corp. Continued Leading Sponsorship at 2025 POSNA Annual Meeting Reinforced Long-Term Commitment as Emerald Sponsor WARSAW, Ind., May 14, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its continued support of the 2025 Pediatric Orthopaedic Society of North America (“POSNA”) annual meeting as an Emerald Sponsor. At the Annual Meeting, the Company will highlight its growing portfolio of pediatric-specific solutions, including...

 PRESS RELEASE

OrthoPediatrics Corp. Reports First Quarter 2025 Financial Results and...

OrthoPediatrics Corp. Reports First Quarter 2025 Financial Results and Increases Full Year 2025 Revenue Guidance First Quarter 2025 Revenue Increased 17% Year-over-Year WARSAW, Ind., May 07, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its financial results for the first quarter ended March 31, 2025. First Quarter 2025 and Business Highlights Helped a record of nearly 39,000 children in the first quarter of 2025Generated total revenue of...

 PRESS RELEASE

OrthoPediatrics Corp. Expands Trauma and Deformity Portfolio with 3P™ ...

OrthoPediatrics Corp. Expands Trauma and Deformity Portfolio with 3P™ Pediatric Plating Platform™ Hip System WARSAW, Ind., May 07, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the expansion of its Trauma and Deformity portfolio with 3P™ Pediatric Plating Platform™ Hip System, the first of several systems in the 3P family. This represents the company’s 5th FDA approval in 2025. 3P Pediatric Plating Platform Hip System is a new plate and scre...

 PRESS RELEASE

OrthoPediatrics Corp. to Report First Quarter Financial Results on May...

OrthoPediatrics Corp. to Report First Quarter Financial Results on May 7, 2025 WARSAW, Ind., April 23, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its first quarter 2025 financial results on May 7, 2025 after the market closes. OrthoPediatrics will host a conference call on Wednesday, May 7, 2025 at 4:30 p.m. ET to discuss the results. Investors interested in listening to the conference call may do so...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch